Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis

ASCENT WORKING GROUP

Research output: Contribution to journalArticlepeer-review

16 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalGastroenterology
Volume166
Issue number1
DOIs
StatePublished - Jan 2024

Funding

Funding CEGIR (U54 AI117804) is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS, and is funded through collaboration between NIAID, NIDDK, and NCATS. CEGIR is also supported by patient advocacy groups including American Partnership for Eosinophilic Disorders (APFED), Campaign Urging Research for Eosinophilic Diseases (CURED), and Eosinophilic Family Coalition (EFC). As a member of the RDCRN, CEGIR is also supported by its Data Management and Coordinating Center (DMCC) (U2CTR002818). Funding support for the DMCC is provided by the National Center for Advancing Translational Sciences (NCATS) and the National Institute of Neurological Disorders and Stroke (NINDS).

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this